LVPEI raises awareness on antimicrobial resistance among medical students
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
Construction will begin this year with the new capacity anticipated by 2025
The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
Testing supporting allergy diagnosis now accessible to more people in more communities
Affordability is key to providing accessible healthcare for Bharat.
Subscribe To Our Newsletter & Stay Updated